Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001477932-24-008415
Filing Date
2024-12-31
Accepted
2024-12-31 14:15:57
Documents
7
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K betrf_6k.htm 6-K 11572
2 MANAGEMENTS DISCUSSION AND ANALYSIS betrf_ex991.htm EX-99.1 207347
3 FINANCIAL STATEMENTS betrf_ex992.htm EX-99.2 742684
4 CEO CERTIFICATION betrf_ex993.htm EX-99.3 8223
5 CFO CERTIFICATION betrf_ex994.htm EX-99.4 8199
6 MATERIAL CHANGE REPORT betrf_ex995.htm EX-99.5 13365
7 betrf_ex991img1.jpg GRAPHIC 4274
  Complete submission text file 0001477932-24-008415.txt   998644
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 438-884-8841
BetterLife Pharma Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 333-161157 | Film No.: 241592428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)